September is Blood Cancer Awareness Month, and the pipeline for leukemia, lymphoma and myeloma is as active as it has been in years.
|Articles|October 7, 2021
Sharing My Knowledge With Others
David Dessert knew that his father carried the BRCA2 mutation, so he told his doctor, who developed a treatment plan accordingly.
Advertisement
David Dessert is a 10-year pancreatic cancer survivor.
David knew that his father carried the BRCA2 mutation, so he told his doctor, who developed a treatment plan accordingly. A genetic test later confirmed the presence of a BRCA2 mutation in David. He has educated himself about pancreatic cancer, and as a survivor shares his knowledge with others.
Read more about David in “
Advertisement
Related to this article
After cancer, taking time to rest and travel can create space to heal, reconnect and remember that life is about more than simply surviving.
Dr. Dina Khalaf explains the ASCERTAIN-V, MyeloMATCH MM1MDS-A01 and HOVON 181 trials and what patients with AML or MDS should ask before enrolling.
Children with diffuse midline glioma who took Keppra lived a median of 20.96 months, compared with 9.92 months for those who did not, a new study found.
A phase 1 trial treated 15 patients with breast cancer that spread to the spinal fluid using a vaccine made from their own immune cells. One patient is now more than three years from diagnosis.
Deborah A. McDowell of OAW explains how patients can prepare for hair loss before chemotherapy starts.
FDA approves an updated Ibtrozi label for locally advanced or metastatic ROS1-positive NSCLC, reflecting nearly four years of response data.
Gentle movement during cancer treatment can help maintain strength, mobility and balance. Follow Jennifer Tipton’s simple exercises to keep your body moving.
Advertisement
Advertisement